Online ISSN: 3007-0244,
Print ISSN:  2410-4280
RESULTS THE USE OF VARIOUS SURGICAL METHODS FOR THE TREATMENT OF PATIENTS WITH DIFFUSE TOXIC GOITER
This article discusses the problems of surgical tactics in diffuse - toxic goiter and its complications, both in the early postoperative period and in the long term. The above complications require surgeons to search for the most optimal method of surgical treatment. Aim: Evaluation of immediate, long-term results and hormonal status with various methods of surgical treatment of diffuse-toxic goiter. Materials and research мethods. The article presents the experience of treating 149 patients. The analysis of immediate and long-term results of surgical interventions in relation to thyroid status is given. In 90 patients, subtotal resection of the thyroid gland was performed, in 31 - thyroidectomy, in 28 cases - embolization of the thyroid artery. Thyroid status was analyzed 1, 6, 12, 24 months after surgery. The patients were divided into subgroups depending on the initial volume of the thyroid gland (less than 45 cm3 and more than 45 cm3). Statistical analysis of numerical series was carried out using the Mann-Whitney method, relative values - using Fisher's two-sided exact test. Research results. A moderate number of postoperative complications was revealed, with a predominance of extirpation of the gland in the group and no extirpation in patients undergoing arterial embolization. On the contrary, a higher incidence of recurrence of the hyperthyroid state was characteristic for the latter group, where it was 28.6% over a follow-up period of 24 months. With subtotal resection, the corresponding indicator was 14.4%; after extirpation, no cases of relapse were observed. Extirpation led to the development of total hypothyroidism in all patients, in other groups this condition was observed in about half of the cases. An excess of the initial gland volume of 45 cm3 was characterized by a sharp increase in the incidence of postoperative hypothyroidism. Conclusions: The use of different approaches to the surgical treatment of diffuse-toxic goiter gives differences in the frequency of perioperative complications (excess during extirpation of the thyroid gland) and late complications. Among the late complications, hypothyroidism dominates, which is subject to compensation with the help of substitution therapy. The frequency of recurrence of thyrotoxicosis has a double dependence on the approach to treatment and the initial volume of the thyroid gland. In order to prevent relapse for surgical treatment of DTG with a gland volume of more than 45 cm3, the most rational is extirpation.
Tolegen A Toleutaev1, Nazarbek B. Omarov1, Meirbek Zh. Aimagambetov1, Tolkyn A. Bulegenov1, Tolegen L. Akparov1, Dinara O. Akhmetzhanova1, Kuanysh T. Karibayev1, 1 NСJSC «Semey Medical University», Semey, Republic of Kazakhstan
1. Aimagambetov M.Zh., Omarov N.B., Masalimov E.O., Auzhanov D.B. et al. Our experience in the treatment of diffuse-toxic and nodular goiter Science of Russia: aims and objectives. 2020 year. 2. Affleck B.D., Swartz K., Brennan J. Surgical considerations and controversies in thyroid and parathyroid surgery. Otolaryng Clin N Am 2004; 36: 159-88. 3. Bartalena L., Marcocci C., Bozaggi F., Panicucci M., Lepri A., Pinchera A. et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy // N Engl J Med 1998; 338: 73-8. 4. Bobanga I.D., McHenry C.R. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy // Best Pract Res Clin Endocrinol Metab. 2019 Aug; 33 (4): 101319. doi: 10.1016 / j.beem.2019.101319. 5. Boger M.S., Perrier N.D. Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism // Surg Clin N Am 2004; 84: 849-74. 6. Chen C.R., Pichurin P., Nagayama Y., Latrofa F., Rapoport B., Mclachlam S.M. The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim // J Clin Invest 2003; 111: 1897-904. 7. Cheng Y., Sun Z., Zhong D., Ren L., Yang H. Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs // Medicine (Baltimore). 2020 Oct 23; 99 (43): e22898. doi: 10.1097 / MD.0000000000022898. 8. De Leo S., Lee S.Y., Braverman L.E. Hyperthyroidism // Lancet. 2016 Aug 27; 388 (10047): 906- 918. doi: 10.1016 / S0140-6736 (16) 00278-6. 9. Esbergenova M.Zh., Zamanbekova Zh.K., Uvataeva Zh.S. et al. The state of the thyroid gland in the population of the areas adjacent to the former Semipalatinsk nuclear test site // Science &Healthcare. 2014. №5, pp.75-78. 10. Galkin E.V., Grakov B.S., Protopopov A.V. First clinical experience of radioendo-vascular functional thyroidectomy in the treatment of diffuse toxic goiter // Vestn Rentgenol Radiol. 1994; 3: 29-35. 11. Glantz S.A. Primer of biostatistics. 7th edition. NY: McGRAW-HILL / - 2006 .-- 768 p 12. Gilbert J. Thyrotoxicosis - investigation and management // Clin Med (Lond). 2017 Jun; 17 (3): 274-277. doi: 10.7861 / clinmedicine.17-3-274. 13. Hermann M., Gschwandtner E., Schneider M., Handgriff L., Prommegger R. Modern thyroid surgery - the surgeon's endocrine-surgical understanding and his responsibility for the extent of surgery and complication rate // Wien Med Wochenschr. 2020 Nov; 170 (15-16): 379-391. doi: 10.1007 / s10354-020-00750-5. 14. Kaminski G., Jaroszuk A., Zybek A., Brzozowski K., Piasecki P., Ziecina P., Ruchala M. The calcium-phosphate balance, modulation of thyroid autoimmune processes and other adverse effects connected with thyroid arterial embolization // Endocrine. 2014 Jun; 46 (2): 292-9. doi: 10.1007 / s12020-013-0072-2. 15. Lin YS, Lin JD, Hsu CC, Yu MC The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism // J Surg Res. 2017 Dec; 220: 112-118. doi: 10.1016 / j.jss.2017.06.091. 16. Liu Z.W., Masterson L., Fish B., Jani P., Chatterjee K. Thyroid surgery for Graves 'disease and Graves' ophthalmopathy // Cochrane Database Syst Rev. 2015 Nov 25; (11): CD010576. doi: 10.1002 / 14651858.CD010576 17. Meyer C., Anderson D., Dong Z., Riddick J.B., Elrod M., Ayala M. Prediction of Thyroid Hormone Replacement Following Thyroid Lobectomy: A Long-term Retrospective Study // OTO Open. 2021 Feb 16; 5 (1): 2473974X21992001. doi: 10.1177 / 2473974X21992001. 18. Mu L., Ren C., Xu J., Guo C., Huang J., Ding K. Total versus near-total thyroidectomy in Graves' disease: a systematic review and meta-analysis of comparative studies // Gland Surg. 2021 Feb; 10 (2): 729-738. doi: 10.21037 / gs-20-757. 19. Napier C. Managing thyrotoxicosis in the acute medical setting // Acute Med. 2018; 17 (1): 44-48. 20. Oriazzi J. Management of Graves' hyperthyroidism. Endocrin Metab Clin N Am 1987; 16: 365-Quérat C, Germain N, Dumollard JM, Estour B, Peoc'h M, Prades JM. Surgical management of hyperthyroidism. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Apr; 132 21. Savoca E., Torabi S.J., Kasle D., Mets E., Hajek M., Waldman E.H. Pediatric thyroidectomies: A surgical subspecialty comparison // Int J Pediatr Otorhinolaryngol. 2020 May; 132: 109945. doi: 10.1016 / j.ijporl.2020.109945. 22. Sellem A., Elajmi W., Mhamed R.B., Oueslati N., Ouertani H., Hammami H. Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease // Pan Afr Med J. 2020 Aug 25; 36: 341. doi: 10.11604 / pamj.2020.36.341.21623. 23. Sharma A., Stan M.N. Thyrotoxicosis: Diagnosis and Management // Mayo Clin Proc. 2019 Jun; 94 (6): 1048-1064. doi: 10.1016 / j.mayocp.2018.10.011. 24. Vacante M., Biondi A., Basile F., Ciuni R., Luca S., Di Saverio S., Buscemi C., Vicari E.S., Borzì A.M. Hypothyroidism as a Predictor of Surgical Outcomes in the Elderly // Front Endocrinol (Lausanne). 2019 Apr 24; 10: 258. doi: 10.3389 / fendo.2019.00258.
Количество просмотров: 439

Ключевые слова:


Библиографическая ссылка

Toleutaev T. A., Omarov N. B., Aimagambetov M. Zh., Akparov T. L., Akhmetzhanova D. O., Karibayev K.T. Results the use of various surgical methods for the treatment of patients with diffuse toxic goiter // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 2, pp. 103-110. doi 10.34689/SH.2021.23.2.010

Авторизируйтесь для отправки комментариев